Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology (Science), Basic and Translation: Molecular Imaging

  • You have access
    Development of a novel radiotracer for imaging T cell lymphoma: 111In-DTPA-Mogamulizumab
    Sho Koyasu, Yoichi Shimizu, Mari Suzukida, Takero Shindo, Masahiro Ono and Yuji Nakamoto
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 63;
  • You have access
    89Zr Labeled Anti-PD-1 Antibody PET Monitors phorbol-12-Myristate-13-Acetate (PMA) induced Modulation of Lymphoma PD-1 Expression.
    Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Young Seok Cho and KYUNG-HAN LEE
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 64;
  • You have access
    Molecular Imaging of Multiple Myeloma Targeting CD46 Using ImmunoPET
    Sinan Wang, Yang Su, Bonell Patino Escobar, Veronica Steri, Byron Hann, Ryan Tang, Youngho Seo, Bin Liu, Arun Wiita and Robert Flavell
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 62;
  • You have access
    Robotic radioguided surgery using a DROP-IN gamma probe - technical insights for different prostate cancer indications
    Paolo Dell'Oglio, Hilda De Barros, Tobias Maurer, Esther Wit, Phillip Stricker, Henk van der Poel, Pim van Leeuwen, Fijs Van Leeuwen and Matthias Van Oosterom
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 67;
  • You have access
    Toll-like receptor 5 in triple-negative breast cancer: a novel reporter for tumor progression
    Dai Shi and Hongcheng Shi
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 65;
  • You have access
    Preclinical evaluation of 89Zr-Df-radiolabeled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
    Ingrid Burvenich, Yit Wooi Goh, Nancy Guo, Hui Gan, Angela Rigopoulos, Zhanqi Liu, Uwe Ackermann, Christian Wichmann, Alexander McDonald, Graeme O'Keefe, Sylvia Gong, Fiona Scott, Linghui Li, Wanping Geng, Anup Zutshi, Yan Lan and Andrew Scott
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 66;
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire